Autolus Therapeutics (AUTL) Leases (2018 - 2025)
Historic Leases for Autolus Therapeutics (AUTL) over the last 8 years, with Q3 2025 value amounting to $56.6 million.
- Autolus Therapeutics' Leases fell 640.96% to $56.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.6 million, marking a year-over-year decrease of 640.96%. This contributed to the annual value of $55.5 million for FY2024, which is 870.69% down from last year.
- According to the latest figures from Q3 2025, Autolus Therapeutics' Leases is $56.6 million, which was down 640.96% from $58.6 million recorded in Q2 2025.
- Over the past 5 years, Autolus Therapeutics' Leases peaked at $60.8 million during Q4 2023, and registered a low of -$902000.0 during Q1 2021.
- Its 5-year average for Leases is $36.0 million, with a median of $54.3 million in 2023.
- Per our database at Business Quant, Autolus Therapeutics' Leases crashed by 21729.52% in 2021 and then surged by 297545.35% in 2023.
- Autolus Therapeutics' Leases (Quarter) stood at $18.8 million in 2021, then grew by 23.62% to $23.2 million in 2022, then surged by 161.92% to $60.8 million in 2023, then decreased by 8.71% to $55.5 million in 2024, then grew by 2.03% to $56.6 million in 2025.
- Its Leases was $56.6 million in Q3 2025, compared to $58.6 million in Q2 2025 and $56.2 million in Q1 2025.